Furthermore, since CX3CL1 levels in the blood are linked to indicators of insulin resistance in people with GDM, researchers investigated whether resveratrol therapy might reduce CX3CL1/CX3CR1 production. Here, CX3CR1 is linked to Insulin resistance.